Celldex Therapeutics, Inc. (CLDX) Total liabilities 2016–2025
Celldex Therapeutics, Inc. (CLDX) total liabilities at each fiscal year-end, per SEC filings.
$55.8MFY2025 · since FY2016: $117.9M → $55.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55.8M | +23.1% |
| FY2024 | $45.3M | +24.4% |
| FY2023 | $36.5M | +37.4% |
| FY2022 | $26.5M | +5.4% |
| FY2021 | $25.2M | -4.9% |
| FY2020 | $26.5M | -8.4% |
| FY2019 | $28.9M | -9.0% |
| FY2018 | $31.7M | -59.9% |
| FY2017 | $79.3M | -32.8% |
| FY2016 | $117.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice